Companies: 10,795·Total market cap: $144.5T
SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated

SBCNASDAQIndustrials● Active
$2.96
$-0.05(-1.64%)
Market Cap$304478395
P/E Ratio
52W High$5.75
52W Low$2.78

SBC Medical Group Holdings Incorporated (SBC) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · SBC · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

4

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

SBC Medical Group Holdings Incorporated insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

SBC insider buying and selling by quarter

SBC insider selling · SBC insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
4.5M2.2M0
2024 Q3
2025 Q2
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · SBC ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

SBC executive sell shares · SBC board member insider trading · SBC insider trading SEC filing

Showing 65 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Aikawa Yoshiyuki

Chairman and CEO · Director

Sale

Date

Apr 28

Shares

465,000

Price

$3.02

Value

$1.41M ⚡

View Form 4 on SEC.gov

Aikawa Yoshiyuki

Chairman and CEO · Director

Sale

Date

Apr 21

Shares

3,100,000

Price

$3.02

Value

$9.37M ⚡

View Form 4 on SEC.gov

Aikawa Yoshiyuki

Chairman and CEO · Director

Sale

Date

Mar 6

Shares

4,422,900

Price

$2.12

Value

$9.38M ⚡

View Form 4 on SEC.gov

MCCOY JOHN B

Director

Award

Date

Nov 30

Shares

216.78

Price

$24.91

Value

$5K

View Form 4 on SEC.gov

REMBE TONI

Director

Award

Date

Nov 30

Shares

80.289

Price

$24.91

Value

$2K

View Form 4 on SEC.gov

KNIGHT CHARLES F

Director

Award

Date

Nov 30

Shares

80.289

Price

$24.91

Value

$2K

View Form 4 on SEC.gov

BUSCH AUGUST A III

Director

Award

Date

Nov 30

Shares

216.78

Price

$24.91

Value

$5K

View Form 4 on SEC.gov

WHITACRE EDWARD E JR

Chairman and CEO · Director

Award

Date

Nov 30

Shares

758.731

Price

$24.91

Value

$19K

View Form 4 on SEC.gov

WILKINS RAYFORD JR

Group President

Award

Date

Nov 30

Shares

669.53

Price

$24.91

Value

$17K

View Form 4 on SEC.gov

STANKEY JOHN T

Sr. Exec. VP and CTO

Award

Date

Nov 30

Shares

184.263

Price

$24.91

Value

$5K

View Form 4 on SEC.gov

STEPHENSON RANDALL L

COO · Director

Award

Date

Nov 30

Shares

1,079.205

Price

$24.91

Value

$27K

View Form 4 on SEC.gov

LINDNER RICHARD G

Sr. Exec. VP and CFO

Award

Date

Nov 30

Shares

660.096

Price

$24.91

Value

$16K

View Form 4 on SEC.gov

MILLER FORREST E

Grp.Pres.Ext.Aff. & Plng.

Award

Date

Nov 30

Shares

244.239

Price

$24.91

Value

$6K

View Form 4 on SEC.gov

KAHAN JAMES S

Sr. Exec. VP-Corp. Dev.

Award

Date

Nov 30

Shares

704.336

Price

$24.91

Value

$18K

View Form 4 on SEC.gov

JENNINGS KAREN E

Sr.Exec. VP-HR and Comm.

Award

Date

Nov 30

Shares

742.754

Price

$24.91

Value

$19K

View Form 4 on SEC.gov

ELLIS JAMES D

Sr.Exec.VP and Gen.Cnsl.

Award

Date

Nov 30

Shares

930.189

Price

$24.91

Value

$23K

View Form 4 on SEC.gov

CALLAWAY JAMES W

Group President

Award

Date

Nov 30

Shares

302.021

Price

$24.91

Value

$8K

View Form 4 on SEC.gov

DORMAN DAVID W

President · Director

Sale

Date

Nov 23

Shares

3,000

Price

$24.79

Value

$74K

View Form 4 on SEC.gov

DORMAN DAVID W

President · Director

Sale

Date

Nov 23

Shares

4,700

Price

$24.78

Value

$116K

View Form 4 on SEC.gov

DORMAN DAVID W

President · Director

Sale

Date

Nov 23

Shares

16,900

Price

$24.77

Value

$419K

View Form 4 on SEC.gov

DORMAN DAVID W

President · Director

Sale

Date

Nov 23

Shares

32,200

Price

$24.76

Value

$797K

View Form 4 on SEC.gov

DORMAN DAVID W

President · Director

Sale

Date

Nov 23

Shares

43,200

Price

$24.75

Value

$1.07M ⚡

View Form 4 on SEC.gov

DORMAN DAVID W

President · Director

Sale

Date

Nov 23

Shares

83,939

Price

$24.80

Value

$2.08M ⚡

View Form 4 on SEC.gov

CICCONI JAMES W

SrEVP-Ext & Legis Affairs

Sale

Date

Nov 23

Shares

568

Price

$24.72

Value

$14K

View Form 4 on SEC.gov

CICCONI JAMES W

SrEVP-Ext & Legis Affairs

Sale

Date

Nov 23

Shares

3,897

Price

$24.73

Value

$96K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About SBC insider trading

SBC insider trades

SBC Medical Group Holdings Incorporated (SBC) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Aikawa Yoshiyuki (Chairman and CEO · Director). Over the past 12 months, 1 insiders have filed transactions with the SEC. SBC insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For SBC Medical Group Holdings Incorporated's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

SBC insider trading · 5 questions

The insiders of SBC Medical Group Holdings Incorporated (SBC) include executives and directors such as Aikawa Yoshiyuki (Chairman and CEO · Director), among others. Over the past 12 months, 1 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

SBC board member insider tradingwho are SBC insidersSBC insider rosterSBC Medical Group Holdings Incorporated executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026